Evidence map›Paper›PMID 27586833›Full record

ReviewThe journal of pain2016

Overlapping Chronic Pain Conditions: Implications for Diagnosis and Classification.

William Maixner, Roger B Fillingim, David A Williams, Shad B Smith, Gary D Slade

4 registry-linked trialsAbstract readReview
In one paragraph

Review in The journal of pain, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 4 registered trials, which are not on this map. Cited by 288 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
288citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04884763 phase2completednot on this mapstarted 2021, after this paper: background citation

A Randomized, Double Blind, Placebo-Controlled Single Center Phase 2 Pilot Study to Assess the Safety and Efficacy of Off-label Subcutaneous Administration of Erenumab-aooe in Patients With Temporomandibular Disorder

TypeinterventionalSponsorIndiana UniversityRan2021 to 2024Enrolled30ConditionsTemporomandibular DisorderArmsErenumab-aooe (EREN) 140 mg s.c. administered every four weeks for a total of five treatments, Placebo (EREN-P) s.c. administered every four weeks for a total of five treatments
NCT05752396 recruitingnot on this mapstarted 2023, after this paper: background citation

Disrupted Spatial and Temporal Nociceptive Filtering in Adolescents With and Risk for Overlapping Pain Conditions

TypeobservationalSponsorChildren's Hospital Medical Center, CincinnatiRan2023 to 2028Enrolled420ConditionsMigraine, Musculoskeletal Pain, Functional Abdominal Pain Disorders, Chronic PainArmsConditioned Pain Modulation, Offset Analgesia, Spatial Summation, Temporal Summation
NCT06939257 recruitingnot on this mapstarted 2025, after this paper: background citation

Pain Outcomes Associated With Exogenous Hormone Therapy in Adults

TypeobservationalSponsorUniversity of Kansas Medical CenterRan2025 to 2029Enrolled200ConditionsPain, Gender Minority Individuals
NCT07474662 narecruitingnot on this mapstarted 2026, after this paper: background citation

Comparing the Effectiveness of Online vs. One-on-one vs. Group Physiotherapy for Treating Myogenic Temporomandibular Disorders: A Randomized Controlled Trial

TypeinterventionalSponsorSemmelweis UniversityRan2026 to 2026Enrolled90ConditionsTemporomandibular Disorders (TMD), Orofacial Pain, Temporo-mandibular Dysfunction, Temporomandibular Joint and Muscle DisorderArmsIndividual physiotherapy, Group physiotherapy, Online physiotherapy
3 · Its place in the literature

Who cites it

288 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review

228 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

William MaixnerCenter for Pain Research and Innovation, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; Center for Translational Pain Medicine, Department of Anesthesiology, Duke University, Durham, North Carolina. Electronic address: william.maixner@duke.edu.
Roger B FillingimPain Research and Intervention Center of Excellence, University of Florida, Gainesville, Florida.
David A WilliamsChronic Pain and Fatigue Research Center, Department of Anesthesiology, University of Michigan, Ann Arbor, Michigan.
Shad B SmithCenter for Pain Research and Innovation, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; Center for Translational Pain Medicine, Department of Anesthesiology, Duke University, Durham, North Carolina.
Gary D SladeCenter for Pain Research and Innovation, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; Department of Dental Ecology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.

Funding

Risk Factors for Onset and Persistence of TMDU01DE017018 · NIDCR · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DIATCHENKO, LUDA, FILLINGIM, ROGER B · 2005 to 2016
$35.9M
Vulvar Vestibulitis syndrome (VVS)P01NS045685 · NINDS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ZOLNOUN, DENNIZ A · 2004 to 2014
$12.5M
COMT &betaAR Polymorphism &Development of Painful TMDR01DE016558 · NIDCR · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DIATCHENKO, LUDA · 2005 to 2009
$1.7M
Biomedical Researcher Development Program in TMJD and Orofacial PainK12DE022793 · NIDCR · UNIV OF NORTH CAROLINA CHAPEL HILL · PI LIM, PEI FENG, MAIXNER, WILLIAM · 2012 to 2016
$1.3M
SYSTEMIC EFFECTS OF PERIODONTITISR01DE011551 · NIDCR · UNIVERSITY OF NORTH CAROLINA CHAPEL HILL · PI BECK, JAMES D · 1996 to 2002
$1.2M
NIDCR NIH HHS K12 DE022793NIDCR NIH HHS R01 DE011551NIDCR NIH HHS R01 DE016558NIDCR NIH HHS U01 DE017018NINDS NIH HHS P01 NS045685
6 · The paper itself

Abstract

unlabelledThere is increasing recognition that many if not most common chronic pain conditions are heterogeneous with a high degree of overlap or coprevalence of other common pain conditions along with influences from biopsychosocial factors. At present, very little attention is given to the high degree of overlap of many common pain conditions when recruiting for clinical trials. As such, many if not most patients enrolled into clinical studies are not representative of most chronic pain patients. The failure to account for the heterogeneous and overlapping nature of most common pain conditions may result in treatment responses of small effect size when these treatments are administered to patients with chronic overlapping pain conditions (COPCs) represented in the general population. In this brief review we describe the concept of COPCs and the putative mechanisms underlying COPCs. Finally, we present a series of recommendations that will advance our understanding of COPCs. PERSPECTIVE: This brief review describes the concept of COPCs. A mechanism-based heuristic model is presented and current knowledge and evidence for COPCs are presented. Finally, a set of recommendations is provided to advance our understanding of COPCs.

Indexed as

Chronic DiseaseChronic PainEvidence-Based MedicineHumansPain ManagementPain Measurementclassificationdiagnosisgenetic factorsOverlapping conditionspain sensitivitypsychological factors

Identifiers

PMID27586833
PMCPMC6193199

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.